GAO Says FDA Slow To Debar Convicted Investigators
The U.S. Food and Drug Administration lags in debarring clinical investigators who have been convicted of crimes from continuing to conduct research or overseeing patient safety in medical trials, according to...To view the full article, register now.
Already a subscriber? Click here to view full article